Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             195 results found
no title author magazine year volume issue page(s) type
1 Author index 2008
 18 S1 p. S61-S65
5 p.
 article
2 DL The ubiquitin-proteolytic system: from bench to bedside Ciechanover, A.
 2008
 18 S1 p. S10-
1 p.
 article
3 Editorial Board 2008
 18 S1 p. i-
1 p.
 article
4 OL Unravelling the mystery of neuroregulation of growth hormone secretion: the first fifty years Reichlin, S.
 2008
 18 S1 p. S1-S2
2 p.
 article
5 OR11,2 A central role of insulin-like growth factor-II in embryonic growth and the development of brain and pancreas in zebrafish Netchine, I.
 2008
 18 S1 p. S22-
1 p.
 article
6 OR9,3 Acid-labile subunit gene mutations: clinical, biochemical and molecular study in two unrelated families Camacho-Hübner, C.
 2008
 18 S1 p. S18-
1 p.
 article
7 OR11,4 A monoclonal antibody that targets a novel site on the beta3 subunit of the alphaVbeta3 integrin blocks lesion development in a porcine model of diabetes accelerated atherosclerosis Maile, L.A.
 2008
 18 S1 p. S22-
1 p.
 article
8 OR6,3 A novel IGF:IGFBP:vitronectin complex for treatments of wounds Upton, Z.
 2008
 18 S1 p. S13-
1 p.
 article
9 OR12,1 Bi-directional resistance pathways relevant to anti-IGF-1R targeted therapy: pathway to clinical development Haluska, P.
 2008
 18 S1 p. S23-
1 p.
 article
10 OR10,3 Bone mineral density in women with Turner syndrome treated with estrogen and growth hormone Abe, K.
 2008
 18 S1 p. S20-S21
2 p.
 article
11 OR7,3 Bone mineral density is a predictor of adiponectin and visfatin in patients with acromegaly Sucunza, N.
 2008
 18 S1 p. S15-
1 p.
 article
12 OR1,4 Cause-specific mortality in patients from the KIMS database and associations with IGF-I standard deviation scores (SDS) Wilton, P.
 2008
 18 S1 p. S3-
1 p.
 article
13 OR9,1 Chimeric vitronectin: IGF-I proteins enhance cell growth and provide a novel defined culture system for stem cells Van Lonkhuyzen, D.
 2008
 18 S1 p. S18-
1 p.
 article
14 OR1,5 Chronic growth hormone (GH) excess is associated with increased aldosterone in mice and humans Bidlingmaier, M.
 2008
 18 S1 p. S4-
1 p.
 article
15 OR7,1 Comparison of the effects of raloxifene and estrogen on growth hormone action in hypopituitary women Birzniece, V.
 2008
 18 S1 p. S14-
1 p.
 article
16 OR4,1 Defective Smad7 regulation contributes to excess IGFBP-3-dependent collagen I production in intestinal strictures in Crohn's disease Flynn, R.S.
 2008
 18 S1 p. S8-
1 p.
 article
17 OR5,4 Depot-specific proteomic analysis of adipose tissue from GHR-/- mice Sackmann-Sala, L.
 2008
 18 S1 p. S11-
1 p.
 article
18 OR5,5 d3-Growth hormone receptor polymorphism is not linked with modulation of IGF-I response to GH in acromegaly Montefusco, L.
 2008
 18 S1 p. S12-
1 p.
 article
19 OR3,4 Differential dose related GH- and IGF-insensitivity in children with idiopathic short stature and low serum IGF-I: comparison with growth hormone-deficient patients Cohen, P.
 2008
 18 S1 p. S7-S8
2 p.
 article
20 OR4,4 D413N mutation of the acid-labile subunit causes defects in secretion and ternary complex formation Baxter, R.C.
 2008
 18 S1 p. S9-
1 p.
 article
21 OR3,6 Effect of environment on growth: auxological and hormonal parameters in African and normal Italian children Boschetti, M.
 2008
 18 S1 p. S8-
1 p.
 article
22 OR9,2 Effects of a rowing-step test on saliva IGF-I levels in athletes Antonelli, G.
 2008
 18 S1 p. S18-
1 p.
 article
23 OR10,4 Effects of two years of growth hormone replacement therapy in adults with GHD in previously treated acromegaly Norrman, L-L.
 2008
 18 S1 p. S21-
1 p.
 article
24 OR3,1 Exon 3 deletion polymorphism of the growth hormone receptor (GHR) and GH response: a report of 97 cases (Manchester) and literature meta-analysis Solomon, M.
 2008
 18 S1 p. S6-S7
2 p.
 article
25 OR1,1 Factors determining inadequate hypoglycaemia during insulin tolerance testing after pituitary surgery Lee, P.
 2008
 18 S1 p. S2-
1 p.
 article
26 OR8,2 FAS mediates IGF-I-induced mitogenesis of breast cancer cells but not non-malignant breast epithelial cells Jarrett, C.
 2008
 18 S1 p. S16-
1 p.
 article
27 OR2,5 Fibronectin exposure reduces efficacy of chemotherapeutic agents on DU145 prostate cancer cells: an effect mediated via IGF-I and beta-1 integrin receptors Perks, C.M.
 2008
 18 S1 p. S5-
1 p.
 article
28 OR1,3 GH deficiency may impair cognitive and functional recovery after stroke Bondanelli, M.
 2008
 18 S1 p. S3-
1 p.
 article
29 OR4,3 Ghrelin reduces hepatic insulin action of IGFBP-1 production Lewitt, M.
 2008
 18 S1 p. S9-
1 p.
 article
30 OR5,1 Grb10-mediated recruitment of Eps15 to the IGF-IR regulates ligand-dependent receptor internalization and signalling Monami, G.
 2008
 18 S1 p. S10-S11
2 p.
 article
31 OR11,5 Hepatic insulin signals are enhanced in rats fed on low-protein diets, a model of IGF resistance Toyoshima, Y.
 2008
 18 S1 p. S23-
1 p.
 article
32 OR13,2 High dose and not low dose growth hormone treatment reverses type 2 diabetes in mice List, E.
 2008
 18 S1 p. S25-
1 p.
 article
33 OR11,3 IGFBP-3 as a unique promising therapeutic target for asthma: IGF-independent cross-talk and interference with NF-kB signalling Oh, Y.
 2008
 18 S1 p. S22-
1 p.
 article
34 OR12,5 IGFBP-5 induces extracellular matrix production via Egr-1 and MAPK-dependent pathways Feghali-Bostwick, C.
 2008
 18 S1 p. S24-
1 p.
 article
35 OR4,2 IGFBP-1 in women and men during the development of type 2 diabetes Lewitt, M.S.
 2008
 18 S1 p. S9-
1 p.
 article
36 OR13,5 IGFBP-2 null mice develop obesity and insulin resistance with aging DeMambro, V.E.
 2008
 18 S1 p. S26-
1 p.
 article
37 OR13,4 IGF-I is an important niche factor that determines placental mesenchymal stem cell fate via specific cell-signaling mechanisms Iosef, C.
 2008
 18 S1 p. S25-S26
2 p.
 article
38 OR8,3 IGF-IR and IR quantification and signaling in murine primary mammary epithelial cells Rowzee, A.M.
 2008
 18 S1 p. S16-
1 p.
 article
39 OR12,4 IGF-IR-dependent activation of Survivin is required in T-antigen-mediated stimulation of proliferation and survival of neural progenitors Gualco, E.
 2008
 18 S1 p. S24-
1 p.
 article
40 OR9,4 IGF-1R ubiquitination: from signaling to receptor degradation Girnita, L.
 2008
 18 S1 p. S19-
1 p.
 article
41 OR12,3 Insulin-like growth factor I protects cells from ER stress-induced apoptosis via enhancement of the adaptive capacity of endoplasmic reticulum Novosyadlyy, R.
 2008
 18 S1 p. S24-
1 p.
 article
42 OR5,2 Insulin receptor substrate (IRS)-1 around endosomes, sorted by adaptor protein (AP)-1, is essential for IGF-I-induced DNA synthesis in L6 myoblasts Matsuo, M.
 2008
 18 S1 p. S11-
1 p.
 article
43 OR9,5 Insulin receptor substrates (IRSs) form a high-molecular-mass complex containing RNAs as well as proteins that function in RNA processing Sone, M.
 2008
 18 S1 p. S19-
1 p.
 article
44 OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells Arvigo, M.
 2008
 18 S1 p. S5-S6
2 p.
 article
45 OR6,5 Intramyocellular lipids during exercise: comparison of growth hormone deficient patients and endurance trained athletes Egger, A.
 2008
 18 S1 p. S13-
1 p.
 article
46 OR11,1 Liver-derived circulating IGF-I is sufficient to restore linear growth in an IGF-I null mouse Wu, Y.
 2008
 18 S1 p. S21-
1 p.
 article
47 OR11,6 Liver-derived IGF-I regulates life span in mice Svensson, J.
 2008
 18 S1 p. S23-
1 p.
 article
48 OR6,4 Marked reductions in bioactive IGF-I during hemodialysis Ivarsen, P.
 2008
 18 S1 p. S13-
1 p.
 article
49 OR5,3 Nedd4 interacts with insulin receptor substrate (IRS)-1 and IRS-2 leading to enhancement of IGF signals through the PI 3-kinase pathway in a different manner Fukushima, T.
 2008
 18 S1 p. S11-
1 p.
 article
50 OR4,6 New insights into metabolism from IGFBP-3 knockout mice Yamada, P.M.
 2008
 18 S1 p. S10-
1 p.
 article
51 OR3,2 Optimization of first year height velocity in short children born SGA by individual GH dose adjustment Land, C.
 2008
 18 S1 p. S7-
1 p.
 article
52 OR10,5 Outcome of quality of life and body composition after discontinuation of growth hormone in adult hypopituitary patients — a randomised placebo-controlled trial Filipsson, H.
 2008
 18 S1 p. S21-
1 p.
 article
53 OR8,4 Overexpression of IRS-1 suppresses initiation of myogenesis through exclusion of Foxo1 from the nucleus in the PI 3-kinase-dependent mechanism Yamauchi, Y.
 2008
 18 S1 p. S16-S17
2 p.
 article
54 OR12,2 p125, a novel PI 3-kinase-associated protein (PITKAP) plays an essential role in cAMP-dependent potentiation of IGF bioactivities in a thyroid cell line Yamanaka, D.
 2008
 18 S1 p. S23-S24
2 p.
 article
55 OR7,2 Pharmacokinetic and pharmacodynamic characterisation of NNC 126-0083, a long-acting growth hormone derivative Thygesen, P.
 2008
 18 S1 p. S14-S15
2 p.
 article
56 OR3,3 Polymorphisms associated with changes in serum IGF-I after GH therapy in children with GHD or Turner syndrome Clayton, P.
 2008
 18 S1 p. S7-
1 p.
 article
57 OR2,2 Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis Koyama, S.
 2008
 18 S1 p. S4-
1 p.
 article
58 OR2,3 Pro-survival growth hormone signaling is activated in response to IGF knockdown in prostate cancer Cobb, L.
 2008
 18 S1 p. S4-S5
2 p.
 article
59 OR4,5 Proteolysis of IGFBP-5 in pregnancy Firth, S.M.
 2008
 18 S1 p. S9-S10
2 p.
 article
60 OR13,6 Regulation of IGF-I receptor signaling and the CUL7 ubiquitin ligase by the Parkinson's Disease protein GIGYF2 Tsiaras, W.G.
 2008
 18 S1 p. S26-
1 p.
 article
61 OR1,2 Risk factors for pituitary dysfunction following moderate or severe traumatic brain injury (TBI) Prodam, F.
 2008
 18 S1 p. S3-
1 p.
 article
62 OR8,1 Role of PTEN in IGF-I signalling on astrocytes Fernández, S.
 2008
 18 S1 p. S16-
1 p.
 article
63 OR6,2 Short stature caused by a novel heterozygous mutation in the IGF-I gene van Duyvenvoorde, H.A.
 2008
 18 S1 p. S12-
1 p.
 article
64 OR2,1 Starvation-dependent differential stress resistance protects normal but not cancer cells against high dose chemotherapy Longo, V.
 2008
 18 S1 p. S4-
1 p.
 article
65 OR6,1 Telomere length is associated with exceptional longevity and is modulated by the IGF system Atzmon, G.
 2008
 18 S1 p. S12-
1 p.
 article
66 OR10,1 Ten-year GH replacement in elderly GH deficient adults increases bone mineral density Svensson, J.
 2008
 18 S1 p. S20-
1 p.
 article
67 OR2,4 The development of multi-dimensional models of serum IGF-I, -II, IGFBP-2 and -3 using artificial neural networks as “composite biomarkers” to predict colorectal cancer Renehan, A.
 2008
 18 S1 p. S5-
1 p.
 article
68 OR7,5 The diagnosis of growth hormone deficiency after adult height achievement Secco, A.
 2008
 18 S1 p. S15-S16
2 p.
 article
69 OR13,1 The impact of fasting on growth hormone signaling and action in muscle and fat tissue in human subjects Moller, L.
 2008
 18 S1 p. S25-
1 p.
 article
70 OR8,5 The molecular mechanism underlying enhanced breast cell migration stimulated by IGF-I:IGFBP-5:VN complexes Hollier, B.
 2008
 18 S1 p. S17-
1 p.
 article
71 OR13,3 The role of autocrine human growth hormone in radioresistance of mammary carcinoma cells Bougen, N.
 2008
 18 S1 p. S25-
1 p.
 article
72 OR3,5 The role of IGF1 system in mediating estrogen effects on growth and epiphyseal proliferation in males: insight from peripubertal aromatase deficiency model Werther, G.
 2008
 18 S1 p. S8-
1 p.
 article
73 OR7,4 The somatotroph response to acylated ghrelin is refractory to the negative GH auto-feedback, but is sensitive to negative IGF-I feedback in man Riganti, F.
 2008
 18 S1 p. S15-
1 p.
 article
74 OR10,2 Three years safety and efficacy of a novel once-a-week sustained release rhGH (LB03002) in treatment-naive prepubertal children with GHD* Peter, F.
 2008
 18 S1 p. S20-
1 p.
 article
75 P-33 ACTH releasing activity of GH releasing peptide-2 in patients with hypothalamo-pituitary diseases Yamakado, Y.
 2008
 18 S1 p. S37-
1 p.
 article
76 P-11 Activation of cAMP responsive element binding protein 1 (CREB1) by stimulation of the Src/ERK pathway is a common mechanism underlying IGF-I receptor upregulation by androgens and estrogens in prostate cancer cells Genua, M.
 2008
 18 S1 p. S30-
1 p.
 article
77 P-27 Adapting and validating Eastern European language versions of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) McKenna, S.
 2008
 18 S1 p. S35-
1 p.
 article
78 P-80 Analysis of cellular effects of epigenetic mutations at the IGF2/H19 locus in Silver–Russell syndrome Kannenberg, K.
 2008
 18 S1 p. S50-
1 p.
 article
79 P-66 An observational, controlled study to compare the prevalence and severity of cardiovascular disease in childhood onset vs. adulthood onset growth hormone deficiency Colao, A.
 2008
 18 S1 p. S46-
1 p.
 article
80 P-48 A PK/PD model for characterisation of NNC 126-0083, a long-acting growth hormone derivative with respect to efficacy, time of duration and dose selection Thygesen, P.
 2008
 18 S1 p. S41-
1 p.
 article
81 P-81 A possible role of IGF system in the abnormal bone formation in achondroplastic subjects Palermo, C.
 2008
 18 S1 p. S50-S51
2 p.
 article
82 P-45 A potential role for growth hormone in injury-induced neurogenesis in the immature rat brain Christophidis, L.
 2008
 18 S1 p. S40-
1 p.
 article
83 P-26 Body mass index (BMI) and waist circumference in growth hormone (GH)-untreated adult-onset hypopituitarism in relation to age-dependent general population normative data Koltowska-Haggstrom, M.
 2008
 18 S1 p. S34-S35
2 p.
 article
84 P-23 Bone mineral density and alkaline phosphatase in growth hormone-treated GH-deficient young adults Conway, G.S.
 2008
 18 S1 p. S33-S34
2 p.
 article
85 P-95 Carnosine up-regulates liver IGF-I and decreases tissue cholesterol Santos, E.
 2008
 18 S1 p. S55-
1 p.
 article
86 P-41 Comparison of growth promoting effect of rhGH and rh IGF-I in patients with isolated GHD type IA Horikawa, R.
 2008
 18 S1 p. S39-
1 p.
 article
87 P-74 Congenital IGF-I deficiency effects on dental morphology and histology in patients with Laron syndrome Wright, T.
 2008
 18 S1 p. S49-
1 p.
 article
88 P-49 Control of IGF-1 and headache during medical treatment in acromegaly Sanno, N.
 2008
 18 S1 p. S41-
1 p.
 article
89 P-76 Correlation between N-terminal pro-B-type natiuretic peptide and left ventricular mass in acromegaly Romanello, G.
 2008
 18 S1 p. S49-
1 p.
 article
90 P-105 CXCR4 expression in lymphocytes of IGF-I deficient mice infected with an intracellular pathogen Cuervo-Escobar, S.
 2008
 18 S1 p. S58-
1 p.
 article
91 P-64 Decreased p44/42 MAPK phosphorylation in gender- or hormone-related but not during age-related adrenal gland growth in mice Bielohuby, M.
 2008
 18 S1 p. S46-
1 p.
 article
92 P-61 Differential signaling by insulin and insulin-like growth factors upon binding to insulin receptor isoform A Sacco, A.
 2008
 18 S1 p. S45-
1 p.
 article
93 P-40 Economic evaluation of somatropin (Norditropin®) for the treatment of short children born SGA in Sweden Twena, N.
 2008
 18 S1 p. S39-
1 p.
 article
94 P-37 Effect of GH therapy on coronary flow reserve, diastolic filling and cardiovascular risk factors in adult GHD Boschetti, M.
 2008
 18 S1 p. S38-
1 p.
 article
95 P-07 Effects of GHR stimulation and blockade on growth of prostate cancer cell lines Strawbridge, R.J.
 2008
 18 S1 p. S28-S29
2 p.
 article
96 P-78 Estimates of the bioactivity of IGF-II in serum from healthy subjects, obese subjects and obese type 2 diabetic patients Frystyk, J.
 2008
 18 S1 p. S50-
1 p.
 article
97 P-89 Function and regulation of insulin-like growth factor binding protein-2 and -3 in ovarian cancer cell models Schuett, B.S.
 2008
 18 S1 p. S53-
1 p.
 article
98 P-44 Gender related IGF-I changes after two years of growth hormone (GH) treatment in GH deficient (GHD) children and adults. Data from the NordiNet® International Outcome Study (IOS) Sävendahl, L.
 2008
 18 S1 p. S40-
1 p.
 article
99 P-73 GF-I treatment of patients with Laron syndrome suppresses thrombopoietin levels but does not affect erythropoietin Shevah, O.
 2008
 18 S1 p. S48-
1 p.
 article
100 P-39 GH Deficiency following traumatic brain injury (TBI) as a cause of female infertility Giampietro, A.
 2008
 18 S1 p. S38-
1 p.
 article
101 P-59 GH fragment measurements: a new laboratory tool for GH state investigation in humans De Palo, E.F.
 2008
 18 S1 p. S44-
1 p.
 article
102 P-30 Growth hormone deficiency and acromegaly have comparable effects on bone mass and osteoporotic fracture risk in adult women Mazziotti, G.
 2008
 18 S1 p. S36-
1 p.
 article
103 P-31 Growth hormone does not affect cardiac function in men with the metabolic syndrome and obstructive sleep apnea Franco, C.
 2008
 18 S1 p. S36-
1 p.
 article
104 P-02 Growth hormone induces chemoresistance in breast cancer cells Zatelli, M.C.
 2008
 18 S1 p. S27-
1 p.
 article
105 P-19 Growth hormone treatment increases obstructive sleep apnea index and neck soft tissue mass in abdominally obese men Koranyi, J.
 2008
 18 S1 p. S32-
1 p.
 article
106 P-20 Growth hormone treatment in patients on hemodialysis is associated with an increase in serum mannose-binding lectin levels Hansen, T.K.
 2008
 18 S1 p. S33-
1 p.
 article
107 P-46 Growth hormone treatment in postmenopausal women, effects on aerobic working capacity and the heart Berggren, A.
 2008
 18 S1 p. S40-S41
2 p.
 article
108 P-94 Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients. Results of a pilot, open, prospective, randomized, controlled study Savastano, S.
 2008
 18 S1 p. S54-
1 p.
 article
109 P-55 Hearing loss in patients with Laron syndrome (primary growth hormone insensitivity) is reversed by early IGF-I replacement therapy Attias, J.
 2008
 18 S1 p. S43-
1 p.
 article
110 P-01 HER receptor signaling confers resistance to the insulin-like growth factor 1 receptor inhibitor, BMS-536924 Haluska, P.
 2008
 18 S1 p. S27-
1 p.
 article
111 P-17 Heterogeneous clinical presentation in patients with yet-unreported type 1 IGF receptor molecular defects Azzi, S.
 2008
 18 S1 p. S32-
1 p.
 article
112 P-65 High fat/low carbohydrate diets: effects on serum IGF-I and bone growth in rats Bielohuby, M.
 2008
 18 S1 p. S46-
1 p.
 article
113 P-86 High molecular mass forms of IGFBP-1 associated with placental cell membranes Masnikosa, R.
 2008
 18 S1 p. S52-
1 p.
 article
114 P-52 High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome Stojanovic, M.
 2008
 18 S1 p. S42-
1 p.
 article
115 P-51 24-h mean acyl-ghrelin levels are decreased in older adults Nass, R.
 2008
 18 S1 p. S42-
1 p.
 article
116 P-84 Human microvascular endothelial cells are sensitive to IGF-I but insensitive to insulin Johansson, G.S.
 2008
 18 S1 p. S51-
1 p.
 article
117 P-91 IGFBP-3 in cellular senescence; molecular and clinical implications Garza, A.E.
 2008
 18 S1 p. S53-S54
2 p.
 article
118 P-43 IGF-I and hemoglobin during GH treatment in children born SGA Rapaport, R.
 2008
 18 S1 p. S39-S40
2 p.
 article
119 P-08 IGF-I, IGFBP-3 and cancer risk: poor performance on discrimination analysis as an explanation of inconsistencies between risk-association studies Renehan, A.G.
 2008
 18 S1 p. S29-
1 p.
 article
120 P-87 IGF-I:IGFBP-3 molar ratio and disease risk: statistical considerations and level of agreement with free IGF-I Renehan, A.G.
 2008
 18 S1 p. S52-
1 p.
 article
121 P-98 IGF II immunohistochemistry in breast cancer (BC). Relationship with several predictive parameters in breast malignancy Giustarini, E.
 2008
 18 S1 p. S56-
1 p.
 article
122 P-71 IGF-I recovers mitochondrial function in critically ill patients Horikawa, R.
 2008
 18 S1 p. S48-
1 p.
 article
123 P-106 IGF-I regulates protein oxidation by modulating proteasome activity Torres, C.
 2008
 18 S1 p. S58-
1 p.
 article
124 P-15 IGF pathway in neuroendocrine cancer: expression and prognostic role Cascella, T.
 2008
 18 S1 p. S31-
1 p.
 article
125 P-12 IGF-1R as therapeutic target in melanoma Girnita, A.
 2008
 18 S1 p. S30-
1 p.
 article
126 P-72 IGF systems at diagnosis in pubertal adolescent with type 1 diabetes mellitus Chisalita, S.I.
 2008
 18 S1 p. S48-
1 p.
 article
127 P-67 IGF Targeting of the IGF-IR as a potential therapeutic strategy in endometrial cancer Attias, Z.
 2008
 18 S1 p. S47-
1 p.
 article
128 P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study Ferraù, F.
 2008
 18 S1 p. S43-S44
2 p.
 article
129 P-104 Insulin and IGF-I receptors play a role in invasion of human trophoblast through MMP-9 activation Vallejo, A.F.
 2008
 18 S1 p. S58-
1 p.
 article
130 P-16 Insulin/IGF system in human pituitary tumour: clinical and patho-biological insight Cascella, T.
 2008
 18 S1 p. S31-
1 p.
 article
131 P-79 Insulin like growth factor 1 in prostate cancer Pidaniĉová, A.
 2008
 18 S1 p. S50-
1 p.
 article
132 P-107 Insulin-like growth factor-I prevents oxidative stress-induced apoptosis through PI3K p110a in myoblasts Matheny, W.
 2008
 18 S1 p. S58-S59
2 p.
 article
133 P-09 Interactions between androgen receptor and BRCA1 in regulation of IGF-I receptor gene expression in prostate cancer cells Schayek, H.
 2008
 18 S1 p. S29-
1 p.
 article
134 P-54 Intravascular large B-cell lymphoma as a cause of reversible hypopituitarism Pekic, S.
 2008
 18 S1 p. S43-
1 p.
 article
135 P-85 Is there a role for vitamin A on the regulation of IGF-I in children? Martinelli Jr., C.E.
 2008
 18 S1 p. S52-
1 p.
 article
136 PL10 Everything in moderation: metabolic effects of GH Jorgensen, J.O.
 2008
 18 S1 p. S19-S20
2 p.
 article
137 PL7 GH signalling Schwartz, J.
 2008
 18 S1 p. S17-
1 p.
 article
138 PL3 How does the GH cell network function to build-up highly ordered GH pulses? Mollard, P.
 2008
 18 S1 p. S6-
1 p.
 article
139 PL2 IGF-I treatment across the lifespan Camacho-Hübner, C.
 2008
 18 S1 p. S2-
1 p.
 article
140 PL4 Imaging insights into hypopituitarism Maghnie, M.
 2008
 18 S1 p. S6-
1 p.
 article
141 PL5 Insulin receptor isoforms in physiology and disease: impact on IGF system Belfiore, A.
 2008
 18 S1 p. S13-S14
2 p.
 article
142 PL8 Long-range chromosomal interactions in the regulation of IGF2 imprinting Hoffman, A.
 2008
 18 S1 p. S17-S18
2 p.
 article
143 PL1 New GH-related molecules with therapeutic potential Ross, R.
 2008
 18 S1 p. S2-
1 p.
 article
144 PL9 Regulation of pancreatic endocrine function by IGF and insulin signalling Accili, D.
 2008
 18 S1 p. S19-
1 p.
 article
145 PL6 The role of the IGF-IR in cancer: initiation and progression or therapeutic target? Plymate, S.
 2008
 18 S1 p. S14-
1 p.
 article
146 P-32 Metabolic complications in patients with adult growth hormone deficiency Kurimoto, M.
 2008
 18 S1 p. S36-
1 p.
 article
147 P-42 Metabolic profile of patients with idiopatic short stature (ISS) according to GH and IGF-I status Martinelli, C.
 2008
 18 S1 p. S39-
1 p.
 article
148 P-28 Metabolic status at baseline and after 3 years of GH treatment in patients with Cushing's disease and non-functioning adenomas: a hypopituitary control and complications study analysis Webb, S.
 2008
 18 S1 p. S35-
1 p.
 article
149 P-10 Mitogenic activity and signaling pathways elicited by long-acting insulin analogues Glargine and Detemir in colon cancer derived cell lines Weinstein, D.
 2008
 18 S1 p. S29-S30
2 p.
 article
150 P-63 Molecular mechanisms underlying the anti-inflammatory action of IGF-I in astrocytes Fernández, A.M.
 2008
 18 S1 p. S45-
1 p.
 article
151 P-75 Muscle expression of MGF, IGF-IEa and myostatin in intact and hypophysectomized rats: effects of rhGH testosterone alone or combined Bonomo, S.M.
 2008
 18 S1 p. S49-
1 p.
 article
152 P-101 Neuronal activity regulates serum IGF-I input to the brain Nishijima, T.
 2008
 18 S1 p. S57-
1 p.
 article
153 P-03 Obestatin and ghrelin function in ovarian cancer cell lines, Walpole, C.
 2008
 18 S1 p. S27-
1 p.
 article
154 P-69 Patients with liver cirrhosis have higher levels of bioactive IGF-I in ascites than in serum Jeyaratnaganthan, N.
 2008
 18 S1 p. S47-
1 p.
 article
155 P-70 Peripheral sensory neuropathy in type 2 diabetes is associated with increased IGFBP-1 Kärvestedt, L.
 2008
 18 S1 p. S47-S48
2 p.
 article
156 P-58 Pharmacokinetics and pharmacodynamics of a single injection of a pegylated long-acting recombinant growth hormone Bysted, B.
 2008
 18 S1 p. S44-
1 p.
 article
157 P-56 Pituitary function in young ischemic stroke patient: preliminary data Di Somma, C.
 2008
 18 S1 p. S43-
1 p.
 article
158 P-97 Predictive value of insulin like growth factor II (IGF-II) mRNA expression in breast cancer (BC) Fiore, E.
 2008
 18 S1 p. S55-
1 p.
 article
159 P-35 Preference of growth hormone provocative test in diagnosing GH deficiency in clinical practice — data from Japanese HypoCCS study Shimatsu, A.
 2008
 18 S1 p. S37-
1 p.
 article
160 P-109 Production of mouse growth hormone antagonist (G118K) Gosney, E.
 2008
 18 S1 p. S59-
1 p.
 article
161 P-100 Promoter haplotype in the insulin-like growth factor-binding protein-3 gene: correlation with serum levels, growth and response to growth hormone treatment in short children born small for gestational age van der Kaay, D.
 2008
 18 S1 p. S56-S57
2 p.
 article
162 P-99 Promoter polymorphism in the insulin-like growth factor-binding protein-1 gene: correlation with serum IGFBP-1 levels and insulin levels in short children born small for gestational age van der Kaay, D.
 2008
 18 S1 p. S56-
1 p.
 article
163 P-38 Prospective comparison of the Glucagon Stimulation Test (GST) with the Insulin Tolerance Test (ITT) in patients following pituitary surgery Berg, C.
 2008
 18 S1 p. S38-
1 p.
 article
164 P-62 Regulation of suppressor of cytokine signalling-2 gene expression in liver and kidney by estradiol, growth hormone and thyroid hormone interaction Santana-Farré, R.
 2008
 18 S1 p. S45-
1 p.
 article
165 P-21 Relationship between IGF-I levels and peripheral nerve enlargement in acromegaly Resmini, E.
 2008
 18 S1 p. S33-
1 p.
 article
166 P-77 Relationships between serum insulin-like growth factor-I levels, blood pressure and glucose tolerance: an observational, exploratory study in 404 subjects Colao, A.
 2008
 18 S1 p. S49-S50
2 p.
 article
167 Program at a glance 2008
 18 S1 p. vi-
1 p.
 article
168 P-88 Role of oxidative stress on the regulation of IGFBP-1 mRNA in protein-deprived rat liver Takenaka, A.
 2008
 18 S1 p. S52-S53
2 p.
 article
169 P-18 Russell-Silver Syndrome: clinical scoring system and molecular investigations on a large series of patients Netchine, I.
 2008
 18 S1 p. S32-
1 p.
 article
170 P-103 Serum levels of IGF-1, IGFBP-1, CoQ10 and Vitamin E in four female populations from Poland, Serbia, and Sweden Tekle, M.
 2008
 18 S1 p. S57-
1 p.
 article
171 P-04 Short-interfering RNA for targeting IGFs in tumour cells Durfort, T.
 2008
 18 S1 p. S28-
1 p.
 article
172 P-60 Signaling differences in the A and B isoforms of the insulin receptor in 32D cells stimulated by either insulin or IGF-II in the presence of IRS-3 Cassarino, M.F.
 2008
 18 S1 p. S44-S45
2 p.
 article
173 P-05 Specific targeting of IGF-I and IGF-IR genes by antigene nucleic acids Oussedik, K.
 2008
 18 S1 p. S28-
1 p.
 article
174 P-83 Study of two IGF-1R gene expression variants Steunou, V.
 2008
 18 S1 p. S51-
1 p.
 article
175 P-50 Sweat secretion in obese subjects with hyposomatotropism Rasmussen, M. Højby
 2008
 18 S1 p. S41-S42
2 p.
 article
176 P-22 Ten-year growth hormone (GH) replacement normalizes muscle strength in GH deficient adults Götherström, G.
 2008
 18 S1 p. S33-
1 p.
 article
177 P-34 The effect of GH-IGF-I axis on renin-angiotensin system (RAS) and cardiac structure and function in patients with acromegaly Tanaka, S.
 2008
 18 S1 p. S37-
1 p.
 article
178 P-47 The effect of growth hormone (GH) and insulin-like growth factor I (IGF-I) on expression of 11β-hydroxysteroid dehydrogenase type1 (HSD1) mRNA in 3T3-L1 adipocytes Ishikawa, Y.
 2008
 18 S1 p. S41-
1 p.
 article
179 P-68 The GH-IGF axis in glycogen storage disease type 1 (GSD): Evidence of different growth patterns and IGF levels in patients with GSD1 A and GSD1 B Pivonello, R.
 2008
 18 S1 p. S47-
1 p.
 article
180 P-14 The IGF-1 receptor inhibitor PPP induces increased cellular uptake of glucose. Interactions between IGF-1R and insulin receptor? Vasilcanu, D.
 2008
 18 S1 p. S31-
1 p.
 article
181 P-90 The IGF system in atherosclerosis. Effect of IGFBP-1 on rat SMC proliferation in different glucose conditions Wang, J.
 2008
 18 S1 p. S53-
1 p.
 article
182 P-92 The influence of glucose intake on the relative abundance of IGFBP-1 phosphoforms in the circulation Nedic, O.
 2008
 18 S1 p. S54-
1 p.
 article
183 P-25 The influences of the standardization of GH assay on the criteria for evaluating the effect of treatment of acromegaly in Japan Fukuda, I.
 2008
 18 S1 p. S34-
1 p.
 article
184 P-96 The new IGF-I-responsive protein EVA promotes survival and migration signalling through regulation of endosomal pH by the V-ATPase O'Callaghan, K.M.
 2008
 18 S1 p. S55-
1 p.
 article
185 P-82 The physiological variability of insulin growth factor I and procollagen type III in amateur and elite athletes: implications in detecting growth hormone abuse in sports Erotokritou, I.
 2008
 18 S1 p. S51-
1 p.
 article
186 P-24 The Power of the Mind: an evaluation of the placebo effect in a study of GH on physical performance Meinhardt, U.
 2008
 18 S1 p. S34-
1 p.
 article
187 P-53 The pre-treatment with acylated ghrelin abolishes the GH response to GHRH and inhibits that to GHRH+ARGININE and ghrelin itself Olivetti, I.
 2008
 18 S1 p. S42-S43
2 p.
 article
188 P-102 The relationship between central adrenal insufficiency and sleep related breathing disorders in children with Prader-Willi syndrome de Lind van Wijngaarden, R.
 2008
 18 S1 p. S57-
1 p.
 article
189 P-29 The response of plasma ACTH and AVP to growth hormone-releasing peptide-2 (GHRP-2) in healthy adults Tanimoto, K.
 2008
 18 S1 p. S35-S36
2 p.
 article
190 P-108 The role of PPARgamma and IGFBP-3 in regulating breast cancer Pon, C.
 2008
 18 S1 p. S59-
1 p.
 article
191 P-06 The roles of ghrelin and obestatin in prostate cancer Amorim, L.
 2008
 18 S1 p. S28-
1 p.
 article
192 P-13 The type 1 insulin-like growth factor receptor (IGF1R) as a therapeutic target in renal cancer Wang, Y.
 2008
 18 S1 p. S30-S31
2 p.
 article
193 P-36 Using the candidate-gene approach to investigate the predictive impact of genetic polymorphisms on response to GH replacement therapy in adults Glad, C.A.M.
 2008
 18 S1 p. S37-S38
2 p.
 article
194 P-93 Visceral fat mass, not total fat mass or body mass index, is the strongest predictor of circulating ghrelin levels in humans Søndergaard, E.
 2008
 18 S1 p. S54-
1 p.
 article
195 Scientific Program 2008
 18 S1 p. vii-xvi
nvt p.
 article
                             195 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands
Toegankelijkheidsverklaring